Remove Accountability Remove Biotechnology Remove Integration Remove Life Sciences
article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%

article thumbnail

Veta Health Apoints CEO, Walgreens Leadership Appointments, Walmart’s New VP, Other Executive Appointments

HIT Consultant

appoints Holly May was appointed Executive Vice President and Global Chief Human Resources Officer, and Anita Allemand was appointed Chief Transformation and Integration Officer. Integrity Applications, Inc. Rebus Biosystems , an Illumina Ventures-backed life science technology company creating?revolutionary?tools?to?advance

article thumbnail

Uber Health Hires First Chief Medical Officer, Aledade’s New CEO, Other Digital Health Appointments

HIT Consultant

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.